ARR at June '18 was $15.4m. Then Zunos was described as having in excess of $3m ARR.
So $18.4ARR / 12 = $1.53m MRR from July '19 plus any growth up until December '19.
ARR and MRR is much higher than FY18 Revenue / 12.
Integration expenses for Zunos were budgeted as part of the acquisition / capital raise so will be expensed presumably before December. So i suspect we see a spike in expenses now but that they reduce come December, hence MRR potentially meeting monthly operating expenses by then. It isn't far fetched but it also doesn't tell the whole story of the underlying business.
I think BTH was trying to say to people look we are building something sustainable here even though expenses balloon due to integrating acquisitions etc. Then I suspect they expect to reap the benefits of the acquisition by selling into each customer base the two products they have as they bring them together etc and offering something with more functionality to market as a holistic product offering.
- Forums
- ASX - By Stock
- BTH
- Ann: Update Revenue growth, operating outcome, customer retention
Ann: Update Revenue growth, operating outcome, customer retention, page-19
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTH (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.015(8.57%) |
Mkt cap ! $135.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.3¢ | 18.0¢ | $805.0K | 4.306M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 97033 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 754034 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23441 | 0.450 |
2 | 15506 | 0.440 |
2 | 31118 | 0.435 |
1 | 10000 | 0.430 |
1 | 15000 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.455 | 8703 | 1 |
0.460 | 44183 | 3 |
0.465 | 5534 | 1 |
0.470 | 101613 | 2 |
0.475 | 24341 | 1 |
Last trade - 14.36pm 25/11/2024 (20 minute delay) ? |
Featured News
BTH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online